European CHMP recommends license extension of Velphoro (polynuclear iron(III)-oxyhydroxide, sucrose and starches)

The CHMP has recommended approval of Velphoro for the control of serum phosphorus levels in paediatric patients 2 years of age and older with chronic kidney disease (CKD) stages 4-5 (or with CKD on dialysis).

Source:

European Medicines Agency